Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
490 DiRECT Cohort: An NCORP longitudinal observational trial for disparities in results of immune checkpoint inhibitor treatment between Black and White cancer patients
Compose a Response to This Article
Other responses
No responses have been published for this article.
